Cargando…

Can Physical Activity Support the Endocannabinoid System in the Preventive and Therapeutic Approach to Neurological Disorders?

The worldwide prevalence of neurological and neurodegenerative disorders, such as depression or Alzheimer’s disease, has spread extensively throughout the last decades, becoming an enormous health issue. Numerous data indicate a distinct correlation between the altered endocannabinoid signaling and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Charytoniuk, Tomasz, Zywno, Hubert, Konstantynowicz-Nowicka, Karolina, Berk, Klaudia, Bzdega, Wiktor, Chabowski, Adrian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7352563/ https://www.ncbi.nlm.nih.gov/pubmed/32545780 http://dx.doi.org/10.3390/ijms21124221

Ejemplares similares

The Endocannabinoid System and Physical Activity—A Robust Duo in the Novel Therapeutic Approach against Metabolic Disorders
por: Charytoniuk, Tomasz, et al.
Publicado: (2022)

Phytocannabinoids—A Green Approach toward Non-Alcoholic Fatty Liver Disease Treatment
por: Berk, Klaudia, et al.
Publicado: (2021)

Molecular Advances in MAFLD—A Link between Sphingolipids and Extracellular Matrix in Development and Progression to Fibrosis
por: Kołakowski, Adrian, et al.
Publicado: (2022)

The Influence of Coumestrol on Sphingolipid Signaling Pathway and Insulin Resistance Development in Primary Rat Hepatocytes
por: Zywno, Hubert, et al.
Publicado: (2021)

Vitamin K2 as a New Modulator of the Ceramide De Novo Synthesis Pathway
por: Kołakowski, Adrian, et al.
Publicado: (2021)

Distinct Effects of Cannabidiol on Sphingolipid Metabolism in Subcutaneous and Visceral Adipose Tissues Derived from High-Fat-Diet-Fed Male Wistar Rats
por: Berk, Klaudia, et al.
Publicado: (2022)

Does the enterolactone (ENL) affect fatty acid transporters and lipid metabolism in liver?
por: Drygalski, Krzysztof, et al.
Publicado: (2017)

Cannabidiol Downregulates Myocardial de Novo Ceramide Synthesis Pathway in a Rat Model of High-Fat Diet-Induced Obesity
por: Charytoniuk, Tomasz, et al.
Publicado: (2022)

How Does CBG Administration Affect Sphingolipid Deposition in the Liver of Insulin-Resistant Rats?
por: Bzdęga, Wiktor, et al.
Publicado: (2023)

N-Acetylcysteine Decreases Myocardial Content of Inflammatory Mediators Preventing the Development of Inflammation State and Oxidative Stress in Rats Subjected to a High-Fat Diet
por: Sztolsztener, Klaudia, et al.
Publicado: (2023)

Experimental Activation of Endocannabinoid System Reveals Antilipotoxic Effects on Cardiac Myocytes
por: Harasim-Symbor, Ewa, et al.
Publicado: (2020)

Time-Dependent Changes in Hepatic Sphingolipid Accumulation and PI3K/Akt/mTOR Signaling Pathway in a Rat Model of NAFLD
por: Sztolsztener, Klaudia, et al.
Publicado: (2021)

Concentration-Dependent Attenuation of Pro-Fibrotic Responses after Cannabigerol Exposure in Primary Rat Hepatocytes Cultured in Palmitate and Fructose Media
por: Sztolsztener, Klaudia, et al.
Publicado: (2023)

High-Fat Feeding in Time-Dependent Manner Affects Metabolic Routes Leading to Nervonic Acid Synthesis in NAFLD
por: Konstantynowicz-Nowicka, Karolina, et al.
Publicado: (2019)

Chronic Cannabidiol Administration Attenuates Skeletal Muscle De Novo Ceramide Synthesis Pathway and Related Metabolic Effects in a Rat Model of High-Fat Diet-Induced Obesity
por: Bielawiec, Patrycja, et al.
Publicado: (2020)

Arachidonic Acid as an Early Indicator of Inflammation during Non-Alcoholic Fatty Liver Disease Development
por: Sztolsztener, Klaudia, et al.
Publicado: (2020)

Attenuation of Oxidative Stress and Inflammatory Response by Chronic Cannabidiol Administration Is Associated with Improved n-6/n-3 PUFA Ratio in the White and Red Skeletal Muscle in a Rat Model of High-Fat Diet-Induced Obesity
por: Bielawiec, Patrycja, et al.
Publicado: (2021)

New Evidence for the Role of Ceramide in the Development of Hepatic Insulin Resistance
por: Konstantynowicz-Nowicka, Karolina, et al.
Publicado: (2015)

Asymptomatic Survivors of Childhood Acute Lymphoblastic Leukemia Demonstrate a Biological Profile of Inflamm-Aging Early in Life
por: Latoch, Eryk, et al.
Publicado: (2022)

Cannabidiol improves muscular lipid profile by affecting the expression of fatty acid transporters and inhibiting de novo lipogenesis
por: Bielawiec, Patrycja, et al.
Publicado: (2023)

Biomarkers of Glucose Metabolism Alterations and the Onset of Metabolic Syndrome in Survivors of Childhood Acute Lymphoblastic Leukemia
por: Konończuk, Katarzyna, et al.
Publicado: (2022)

Endocannabinoid Receptors in the CNS: Potential Drug Targets for the Prevention and Treatment of Neurologic and Psychiatric Disorders
por: Estrada, José Antonio, et al.
Publicado: (2020)

Apolipoproteins—New Biomarkers of Overweight and Obesity among Childhood Acute Lymphoblastic Leukemia Survivors?
por: Sztolsztener, Klaudia, et al.
Publicado: (2022)

Endocannabinoids and cardiovascular prevention: real progress?
por: NODARI, SAVINA, et al.
Publicado: (2007)

Endocannabinoid dysfunction in neurological disease: neuro-ocular DAGLA-related syndrome
por: Bainbridge, Matthew N, et al.
Publicado: (2022)

The Endocannabinoid System as a Therapeutic Target in Glaucoma
por: Cairns, Elizabeth A., et al.
Publicado: (2016)

Therapeutic Opportunities through the Modulation of Endocannabinoid Transport
por: Guo, Jason J, et al.
Publicado: (2013)

The Endocannabinoid System: A Potential Therapeutic Target for Coagulopathies
por: Khayat, Wujood, et al.
Publicado: (2022)

Role of the endocannabinoid system in the pathophysiology of endometriosis and therapeutic implications
por: Lingegowda, Harshavardhan, et al.
Publicado: (2022)

The Therapeutic Potential of the Endocannabinoid System in Age-Related Diseases
por: Tudorancea, Ivona Maria, et al.
Publicado: (2022)

Antioxidants Supplementation Reduces Ceramide Synthesis Improving the Cardiac Insulin Transduction Pathway in a Rodent Model of Obesity
por: Hodun, Katarzyna, et al.
Publicado: (2021)

The Role of Endocannabinoids System in Fatty Liver Disease and Therapeutic Potentials
por: Alswat, Khalid A.
Publicado: (2013)

The Endocannabinoid System in the Retina: From Physiology to Practical and Therapeutic Applications
por: Schwitzer, Thomas, et al.
Publicado: (2016)

Endocannabinoid-Mediated Neuromodulation in the Olfactory Bulb: Functional and Therapeutic Significance
por: Bhatia-Dey, Naina, et al.
Publicado: (2020)

Endocannabinoid System as Therapeutic Target of PTSD: A Systematic Review
por: Steardo, Luca, et al.
Publicado: (2021)

Endocannabinoid system components as potential neuroimmune therapeutic targets in tinnitus
por: Bhat, Vishweshwara, et al.
Publicado: (2023)

Endocannabinoids and Schizophrenia
por: Desfossés, Joëlle, et al.
Publicado: (2010)

Endocannabinoids and Reproduction
por: Meccariello, Rosaria, et al.
Publicado: (2014)

Endocannabinoids and Immunity
por: Chiurchiù, Valerio
Publicado: (2016)

Endocannabinoids in the Gut
por: DiPatrizio, Nicholas V.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_j88ibtp4520hujir6is85tncnk